10-K/APeriod: FY2002

JOHNSON & JOHNSON Annual Report (Amendment), Year Ended Dec 29, 2002

Filed June 26, 2003For Securities:JNJ

Summary

This 10-K/A filing for Johnson & Johnson (JNJ) covers the fiscal year ended December 28, 2002, and serves as an amendment to their annual report. The filing confirms JNJ's status as a well-established, publicly traded entity with its common stock listed on the New York Stock Exchange. A significant point for investors is the substantial market capitalization, with the aggregate market value of non-affiliate shares exceeding $156 billion as of June 28, 2002, underscoring the company's immense scale and investor confidence. The company has met its reporting obligations, filing all required reports for the preceding 12 months and adhering to filing requirements for the past 90 days. This amendment, filed on June 25, 2003, provides updated or supplementary information related to the 2002 fiscal year. Investors should note that key operational details and financial performance figures for 2002 would typically be found within the referenced annual report to shareowners and the proxy statement for the 2003 annual meeting.

Key Highlights

  • 1Johnson & Johnson (JNJ) filed an amendment (10-K/A) to its annual report for the fiscal year ended December 28, 2002.
  • 2The company's common stock is listed and traded on the New York Stock Exchange.
  • 3As of June 28, 2002, the aggregate market value of JNJ's non-affiliate shares was approximately $156 billion, indicating a very large market capitalization.
  • 4JNJ has complied with SEC filing requirements, having filed all necessary reports for the preceding 12 months and the past 90 days.
  • 5The filing date for this amendment was June 25, 2003.
  • 6The company has 2,969,972,365 shares of Common Stock outstanding as of February 25, 2003.
  • 7Key details of the annual report are incorporated by reference from the 2002 annual report to shareowners and the 2003 proxy statement.

Frequently Asked Questions

This filing is an amendment (10-K/A) to Johnson & Johnson's (JNJ) Annual Report for the fiscal year ended December 28, 2002. Amendments are typically filed to provide updated, corrected, or supplementary information that was not included or was incorrect in the original filing.

The aggregate market value of non-affiliate shares exceeding $156 billion as of June 28, 2002, signifies that Johnson & Johnson was a very large-cap company at that time. This generally implies a stable, established business with significant market presence and investor confidence.

The detailed financial performance and operational results for the fiscal year 2002 are incorporated by reference. Specifically, Parts I and II of this Form 10-K/A refer to portions of Johnson & Johnson's annual report to shareowners for fiscal year 2002, and Part III refers to its 2003 proxy statement.

Yes, the filing indicates that Johnson & Johnson has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and has been subject to such filing requirements for the past 90 days, marking it as compliant.